2019 Multidisciplinary Thoracic Cancers Symposium Press Kit
WATCH – Presscast: Highlights from the 2019 Multidisciplinary Thoracic Cancers Symposium
The 2019 Multidisciplinary Thoracic Cancers Symposium is a two-and-a-half-day meeting that convenes radiation and medical oncologists, thoracic surgeons and all members of the treatment team for a practical and comprehensive examination of current thoracic cancer care. Scientific, interactive and case-based educational sessions will cover the latest research on multidisciplinary therapies, clinical applications and new treatment strategies, supportive care and toxicity mitigation. The meeting is cosponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO) and The Society of Thoracic Surgeons (STS).
Information about the press program, which will highlight top-rated research from the symposium, will be available in February 2019. For general information, visit the symposium website.
Researchers presented findings from three top-rated studies in an online presscast on Tuesday, March 12, 2019. A combined news release and the full slide set are available for download.
Studies featured in the presscast include:
Improved Overall Survival with Local Consolidative Therapy in Oligometastatic Non-small Cell Lung Cancer: Results from a Cohort of 194 Patients with Synchronous Disease (Abstract 1), presented by Dr. Erin Corsini, University of Texas MD Anderson Cancer Center
The Impact of the Stage III Randomized Trial by Takahashi et al. on the Use of Prophylactic Cranial Irradiation (PCI) in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (Abstract 3), presented by Dr. Olsi Gjyshi, University of Texas MD Anderson Cancer Center
The Impact of Structured, Prospective Exposure to the NCCN Guidelines when Making Treatment Decisions: Improved Metrics of Guideline-Concordant Care for Patients with Non-small Cell Lung Cancer (Abstract 5), presented by Dr. Susan Wu, University of California, San Francisco
Complimentary registration is available for professional journalists representing media organizations for the express purpose of gathering news and information to produce press coverage of the symposium. Press registration is open to representatives of print, broadcast and online media outlets, including health care trade media (collectively known as press), as well as public information officers from educational institutions, government agencies and nonprofit cancer research organizations presenting research at the symposium.
Applicants may be asked to provide media credentials, a letter of assignment and/or bylined articles. Exhibitors are not permitted to register as press unless they can provide proof of editorial assignment from an accredited news organization that meets the above criteria. Public relations, marketing and/or advertising representatives, financial analysts, book publishers and book authors, and individuals from communications, print or online promotion services are welcome to register as regular attendees, however, they are not permitted to register as press. ASTRO reserves the right to bar from this and future meetings any journalist who misuses press privileges to engage in activities other than journalistic pursuits.
Access the press registration form.
Questions about the press program, press office, press registration and expert availability may be directed to ASTRO’s media relations team at 703-286-1600.
Embargo Policy and Access to Abstracts
All abstracts to be presented at the 2019 Multidisciplinary Thoracic Cancers Symposium are embargoed until 8:00 a.m. Pacific time, Thursday, March 14, 2019, or until they are presented at an ASTRO news briefing, whichever occurs first. The embargo policy applies to all abstracts regardless of whether information is obtained from another source. Embargo violations by media professionals may result in suspension of credentials at the symposium well as future meetings and may also impact the ability to receive advance media materials for future meetings. Embargo violations by abstract authors and/or sponsors may result in removal of the abstract from the scientific program. Abstract authors are responsible for notifying financial and other sponsors about this embargo policy.
Questions about the embargo policy may be directed to ASTRO’s media relations team.
The full text of the abstracts selected for oral and poster presentation will be available online at the start of the symposium. Abstracts also will be published in a supplement of the International Journal of Radiation Oncology • Biology • Physics (www.redjournal.org).
News Planning Team
Aaron S. Mansfield, MD, Mayo Clinic
Daniel R. Gomez, MD, Memorial Sloan Kettering Cancer Center
Jessica Donington, MD, Symposium Co-chair, University of Chicago
Mark K. Ferguson, MD, Program Chair, University of Chicago
Nathan A. Pennell, MD, PhD, Symposium Co-chair, Cleveland Clinic
Ramesh Rengan, MD, PhD, Symposium Co-chair, University of Washington
View disclosures for the news planning team members.